Infliximab으로 호전된 장관 증상없이 발생한 구강-안면 크론병 1예
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 정보용 | - |
dc.contributor.author | 이석호 | - |
dc.contributor.author | 정승규 | - |
dc.contributor.author | 이창균 | - |
dc.contributor.author | 이태훈 | - |
dc.contributor.author | 정일권 | - |
dc.contributor.author | 김선주 | - |
dc.contributor.author | 조현득 | - |
dc.date.accessioned | 2021-08-12T04:25:53Z | - |
dc.date.available | 2021-08-12T04:25:53Z | - |
dc.date.issued | 2012 | - |
dc.identifier.issn | 1598-9992 | - |
dc.identifier.issn | 2233-6869 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/sch/handle/2021.sw.sch/15798 | - |
dc.description.abstract | Crohn’s disease is a chronic inflammatory bowel disease that can involve the whole gastrointestinal tract. The orofacial manifestation of Crohn’s disease, which is rare, can develop irrespective of intestinal involvement. These orofacial lesions are often misdiagnosed as simple oral ulcers. Corticosteroids are the mainstay of therapy for orofacial Crohn’s disease. However, infliximab,the chimeric monoclonal antibody to tumor necrosis factor-α, is now considered as a primary treatment because of the disease’s relatively high rate of steroid resistance. We present a case of deep oral ulcer and periorbital swelling in a 65-year-old woman. She was diagnosed with intestinal Crohn’s disease 7 years ago, which was in remission after treatment with an immunosuppressive agent (azathioprine). The patient was given the diagnosed with orofacial Crohn’s disease and successfully treated with infliximab. | - |
dc.format.extent | 4 | - |
dc.language | 한국어 | - |
dc.language.iso | KOR | - |
dc.publisher | 대한소화기학회 | - |
dc.title | Infliximab으로 호전된 장관 증상없이 발생한 구강-안면 크론병 1예 | - |
dc.title.alternative | Successful Primary Infliximab Treatment of Orofacial Crohn’s Disease without Gastrointestinal Manifestation | - |
dc.type | Article | - |
dc.publisher.location | 대한민국 | - |
dc.identifier.bibliographicCitation | 대한소화기학회지, v.59, no.6, pp 437 - 440 | - |
dc.citation.title | 대한소화기학회지 | - |
dc.citation.volume | 59 | - |
dc.citation.number | 6 | - |
dc.citation.startPage | 437 | - |
dc.citation.endPage | 440 | - |
dc.identifier.kciid | ART001668330 | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
dc.subject.keywordAuthor | Orofacial Crohn’s disease | - |
dc.subject.keywordAuthor | Oral ulcer | - |
dc.subject.keywordAuthor | infliximab | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(31538) 22, Soonchunhyang-ro, Asan-si, Chungcheongnam-do, Republic of Korea+82-41-530-1114
COPYRIGHT 2021 by SOONCHUNHYANG UNIVERSITY ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.